FEMY: Femasys Inc

FEMY新闻

• 14:53 Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment
• 23:06 Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232
• 23:05 Pharmacyte Biotech CEO Silverman buys $80k in shares
• 14:23 Femasys receives FDA clearance for FemVue Controlled diagnostic device
• 15:39 PharmaCyte Biotech股价在成功出售Femasys股份后飙升
• 15:39 PharmaCyte Biotech stock soars after successful Femasys stake sale
• 14:21 PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million
• 06:54 Laidlaw以FemaSeed潜力为由给Femasys股票评级为"买入"
• 06:52 Laidlaw initiates Femasys stock with Buy rating on FemaSeed potential
• 13:40 FDA批准Femasys继续进行非手术永久避孕关键试验
• 13:37 FDA approves Femasys to continue pivotal trial for non-surgical birth control
• 13:08 Femasys在欧盟开始非手术避孕方法的上市后研究
• 13:05 Femasys begins post-market study for non-surgical birth control in EU
• 13:25 Femasys表示近期融资后已满足纳斯达克股权要求
• 13:25 Femasys says it meets Nasdaq equity requirement after recent financing
• 21:30 Femasys首席运营官Daniel Currie将于12月退休
• 21:29 Femasys chief operating officer Daniel Currie to retire in December
• 09:01 Why AMD Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket - Arteris (NASDAQ:AIP), Advanced Micro Devices (NASDAQ:AMD)
• 13:09 Femasys partners with MES to launch sperm analysis kit
• 16:16 Crude Oil Down 2%; US Durable Goods Orders Decline In July - Domo (NASDAQ:DOMO), Allarity Therapeutics (NASDAQ:ALLR)
• 14:13 Femasys stock plunges after pricing public offering at steep discount
• 13:55 US Stocks Mixed; American Woodmark Posts Downbeat Sales - American Woodmark (NASDAQ:AMWD), Allarity Therapeutics (NASDAQ:ALLR)
• 09:52 Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket - Beneficient (NASDAQ:BENF), Battalion Oil (AMEX:BATL)
• 03:49 Femasys prices $8 million public offering to fund growth initiatives